Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Disulfiram | 1 | 2017 | 34 | 0.540 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2017 | 262 | 0.500 |
Why?
|
Down Syndrome | 1 | 2017 | 198 | 0.450 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 717 | 0.400 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 538 | 0.360 |
Why?
|
Mutation | 2 | 2018 | 5825 | 0.220 |
Why?
|
Survivorship | 1 | 2023 | 36 | 0.210 |
Why?
|
Patient Preference | 1 | 2023 | 118 | 0.200 |
Why?
|
Yttrium Radioisotopes | 1 | 2021 | 18 | 0.190 |
Why?
|
Lactams | 1 | 2021 | 14 | 0.190 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2021 | 10 | 0.190 |
Why?
|
Pyrazoles | 2 | 2021 | 304 | 0.180 |
Why?
|
Thoracic Neoplasms | 1 | 2021 | 38 | 0.180 |
Why?
|
Aminopyridines | 1 | 2021 | 55 | 0.180 |
Why?
|
Cancer Survivors | 1 | 2023 | 209 | 0.170 |
Why?
|
Cytarabine | 2 | 2018 | 98 | 0.170 |
Why?
|
Embolization, Therapeutic | 1 | 2021 | 222 | 0.160 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2018 | 38 | 0.150 |
Why?
|
Caregivers | 1 | 2023 | 575 | 0.150 |
Why?
|
Pyrimidinones | 1 | 2018 | 40 | 0.150 |
Why?
|
Drug Resistance | 1 | 2018 | 257 | 0.140 |
Why?
|
Pyridones | 1 | 2018 | 110 | 0.140 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2017 | 40 | 0.140 |
Why?
|
Bortezomib | 1 | 2017 | 73 | 0.130 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 310 | 0.130 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2018 | 224 | 0.120 |
Why?
|
Cell Survival | 1 | 2017 | 806 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 529 | 0.110 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 931 | 0.100 |
Why?
|
Brain Neoplasms | 1 | 2021 | 1212 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 1662 | 0.100 |
Why?
|
Liver Neoplasms | 1 | 2021 | 1313 | 0.090 |
Why?
|
Adolescent | 5 | 2023 | 19287 | 0.090 |
Why?
|
Cell Proliferation | 1 | 2017 | 2285 | 0.080 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 3335 | 0.080 |
Why?
|
Neoplasms | 1 | 2023 | 2788 | 0.080 |
Why?
|
Young Adult | 2 | 2023 | 9024 | 0.070 |
Why?
|
Child | 3 | 2023 | 24386 | 0.060 |
Why?
|
Male | 5 | 2023 | 61270 | 0.050 |
Why?
|
Middle Aged | 2 | 2023 | 26797 | 0.050 |
Why?
|
Infant | 1 | 2017 | 12475 | 0.050 |
Why?
|
Adult | 2 | 2023 | 29489 | 0.050 |
Why?
|
Child, Preschool | 1 | 2017 | 14018 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2021 | 75 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 209 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 209 | 0.040 |
Why?
|
Butadienes | 1 | 2018 | 19 | 0.040 |
Why?
|
Thiophenes | 1 | 2018 | 59 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 545 | 0.040 |
Why?
|
Humans | 5 | 2023 | 124728 | 0.040 |
Why?
|
Nitriles | 1 | 2018 | 146 | 0.040 |
Why?
|
Vincristine | 1 | 2018 | 191 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2018 | 622 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2018 | 167 | 0.030 |
Why?
|
Parents | 1 | 2023 | 1015 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2018 | 526 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2018 | 317 | 0.030 |
Why?
|
Proteins | 1 | 2021 | 1036 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2018 | 737 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 354 | 0.030 |
Why?
|
Exons | 1 | 2018 | 796 | 0.030 |
Why?
|
Female | 2 | 2023 | 66570 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 766 | 0.030 |
Why?
|
Texas | 1 | 2023 | 3586 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 1163 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 1233 | 0.030 |
Why?
|
Surveys and Questionnaires | 1 | 2023 | 3716 | 0.030 |
Why?
|
Prognosis | 1 | 2021 | 4627 | 0.020 |
Why?
|
Disease Progression | 1 | 2018 | 2049 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 1199 | 0.020 |
Why?
|
Brain | 1 | 2021 | 2982 | 0.020 |
Why?
|